WEST CHESTER, Pa. — June  10, 2010 — Chiral Technologies, Inc. (CTI), the world's leading supplier of chirality tools, is partnering with Vanderbilt University’s Program in Drug Discovery (VPDD) to supply enantioselective chiral chromatography columns and custom separation services. VPDD is a premier university-run drug discovery program. It employs more than 60 scientists working with major pharmaceutical companies, government laboratories and private foundations to accelerate speed and enhance the drug discovery and development processes.